1013491

STI Pharma LLC — FEI 3008910005

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 17, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Newtown, PA (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)